Abliva
Ticker/ISIN
ABLI
SE0002575340
Marknad/Land
SE
Sweden
Senaste aktiekurs
0.16 SEK
2024-03-03
Hittills i år
-0.35 %
3 månader
0.00 %
6 månader
0.00 %
1 år
-0.26 %
3 år
-0.68 %
5 år
-0.88 %
NeuroVive Pharmaceutical AB, a leading mitochondrial medicine company, is developing a portfolio of products to treat acute cardiovascular and neurological conditions through mitochondrial protection. These medical conditions are characterized by a pressing medicinal need and have no approved pharmaceutical treatment options at present. NeuroVive’s products CicloMulsion® (heart attack) and NeuroSTAT® (traumatic brain injury) are currently being evaluated in phase III and phase II studies, respectively. NeuroVive’s research programs also include products for the treatment of anti-viral indications (Hepatitis B/C), brain cell injury in stroke patients, and drug candidates for cellular protection and treating mitochondria-related energy regulation diseases. NeuroVive’s shares are listed on NASDAQ OMX, Stockholm, Sweden.
Threads
Inga nyheter funna